Reply to the Comments on “Recent Human Papillomavirus Vaccination is Associated with a Lower Risk of COVID-19: A US Database Cohort Study”
Thomas Yen-Ting Chen1,2, Qianru Zhang3,4, Yao-Min Hung5,6,7, Renin Chang8,9,10,11, Shiow-Ing Wang11,12, James Cheng-Chung Wei11,13,14,15
1Department of Otolaryngology—Head and Neck Surgery, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
2Harvard T.H. Chan School of Public Health, Boston, USA
3Department of Rheumatology and Immunology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beijing, China
4Harvard Medical School, Boston, USA
5Division of Nephrology, Department of Internal Medicine, Taipei Veterans General Hospital Taitung Branch, Taipei, Taiwan
6Master Program in Biomedicine, College of Science and Engineering, National Taitung University, Taitung, Taiwan
7College of Health and Nursing, Meiho University, Pingtung, Taiwan
8Department of Medical Education and Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
9Department of Emergency Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan
10Department of Recreation and Sports Management, Tajen University, Pingtung, Taiwan
11Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
12Center for health data science, Chung Shan Medical University Hospital, Taichung, Taiwan
13Department of Nursing, Chung Shan Medical University, Taichung, Taiwan
14Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan
15Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan